Curanex Pharmaceuticals Inc
CURX
$0.60
-$0.01-1.78%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 361.20K | 347.70K | 290.40K | 239.20K | 137.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 361.20K | 347.70K | 290.40K | 239.20K | 137.20K |
| Operating Income | -361.20K | -347.70K | -290.40K | -239.20K | -137.20K |
| Income Before Tax | -435.00K | -418.90K | -361.50K | -237.00K | -137.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.44 | -0.42 | -0.36 | -0.24 | -0.14 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -435.00K | -418.90K | -361.50K | -237.00K | -137.10K |
| EBIT | -361.20K | -347.70K | -290.40K | -239.20K | -137.20K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.02 | -0.03 | -0.16 | -0.18 | -0.17 |
| Normalized Basic EPS | -0.01 | -0.02 | -0.10 | -0.11 | -0.11 |
| EPS Diluted | -0.02 | -0.03 | -0.16 | -0.18 | -0.17 |
| Normalized Diluted EPS | -0.01 | -0.02 | -0.10 | -0.11 | -0.11 |
| Average Basic Shares Outstanding | 96.24M | 74.64M | 51.24M | 27.76M | 4.20M |
| Average Diluted Shares Outstanding | 96.24M | 74.64M | 51.24M | 27.76M | 4.20M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |